new multiplex kit for COVID-19 and flu A, B type diagnostics

new multiplex kit for COVID-19 and flu A, B type diagnostics

Charles University (UK) Rector Tomas Zima gives briefing to present new multiplex kit for COVID-19 and flu A, B type diagnostics from GeneSpector company, UK subsidiary, at Charles University, Prague, Czech Republic, on Tuesday, October 6, 2020. (CTK Photo/Michal Kamaryt)

  • Product Code
  • ILEA000268966
  • Registered date
  • 2020/10/06 00:00:00
  • Credit
  • CTK / Kyodo News Images
  • Media source
  • CTK
  • Media size
  • 4464 × 2976 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 10.47(MB)*
  • Special instruction
  • SLOVAKIA OUT, CZECH REPUBLIC OUT
    **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    State Institute for Drug Control, building, headquarters

    State Institute for Drug Control, building, headquarters

    The building of the State Institute for Drug Control in Prague, Czech Republic, April 9, 2021. (CTK Photo/Vojtech Vlk)
      State Institute for Drug Control, building, headquarters, face mask

      State Institute for Drug Control, building, headquarters, face mask

      The building of the State Institute for Drug Control in Prague, Czech Republic, April 9, 2021. (CTK Photo/Vojtech Vlk)
        State Institute for Drug Control, building, headquarters

        State Institute for Drug Control, building, headquarters

        The building of the State Institute for Drug Control in Prague, Czech Republic, April 9, 2021. (CTK Photo/Vojtech Vlk)
          State Institute for Drug Control, building, headquarters

          State Institute for Drug Control, building, headquarters

          The building of the State Institute for Drug Control in Prague, Czech Republic, April 9, 2021. (CTK Photo/Vojtech Vlk)
            State Institute for Drug Control, building, headquarters

            State Institute for Drug Control, building, headquarters

            The building of the State Institute for Drug Control in Prague, Czech Republic, April 9, 2021. (CTK Photo/Vojtech Vlk)
              Zdenek Benes, bamlanivimab anti-COVID drug

              Zdenek Benes, bamlanivimab anti-COVID drug

              Zdenek Benes, director of the Thomayer University Hospital attends a press conference on received bamlanivimab anti-COVID drug supply, on February 26, 2021, in Prague, Czech Republic. (CTK Photo/Ondrej Deml)
                Zdenek Benes, bamlanivimab anti-COVID drug

                Zdenek Benes, bamlanivimab anti-COVID drug

                Zdenek Benes, director of the Thomayer University Hospital attends a press conference on received bamlanivimab anti-COVID drug supply, on February 26, 2021, in Prague, Czech Republic. (CTK Photo/Ondrej Deml)
                  Irena Storova

                  Irena Storova

                  The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)
                    Irena Storova

                    Irena Storova

                    The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)
                      Irena Storova

                      Irena Storova

                      The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)